ANGO
Income statement / Annual
Last year (2025), AngioDynamics, Inc.'s total revenue was $292.50 M,
a decrease of 3.76% from the previous year.
In 2025, AngioDynamics, Inc.'s net income was -$33.99 M.
See AngioDynamics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
05/31/2025 |
05/31/2024 |
05/31/2023 |
05/31/2022 |
05/31/2021 |
05/31/2020 |
05/31/2019 |
05/31/2018 |
05/31/2017 |
05/31/2016 |
| Operating Revenue |
$292.50 M |
$303.91 M |
$338.75 M |
$316.22 M |
$291.01 M |
$264.16 M |
$359.48 M |
$344.29 M |
$349.64 M |
$353.69 M |
| Cost of Revenue |
$134.79 M
|
$149.22 M
|
$164.51 M
|
$150.49 M
|
$134.22 M
|
$113.89 M
|
$114.63 M
|
$117.80 M
|
$125.84 M
|
$179.57 M
|
| Gross Profit |
$157.71 M
|
$154.70 M
|
$174.25 M
|
$165.73 M
|
$156.79 M
|
$150.27 M
|
$156.00 M
|
$143.86 M
|
$143.95 M
|
$174.32 M
|
| Gross Profit Ratio |
0.54
|
0.51
|
0.51
|
0.52
|
0.54
|
0.57
|
0.43
|
0.42
|
0.41
|
0.49
|
| Research and Development Expenses |
$26.22 M
|
$31.51 M
|
$29.88 M
|
$30.74 M
|
$36.39 M
|
$29.68 M
|
$29.44 M
|
$25.46 M
|
$25.27 M
|
$25.13 M
|
| General & Administrative Expenses |
$42.09 M
|
$41.16 M
|
$40.00 M
|
$38.45 M
|
$35.92 M
|
$37.87 M
|
$35.17 M
|
$31.27 M
|
$31.41 M
|
$29.21 M
|
| Selling & Marketing Expenses |
$103.14 M
|
$102.82 M
|
$104.25 M
|
$95.30 M
|
$81.31 M
|
$78.63 M
|
$80.96 M
|
$77.28 M
|
$78.82 M
|
$84.91 M
|
| Selling, General & Administrative Expenses |
$145.23 M
|
$143.98 M
|
$144.25 M
|
$133.75 M
|
$117.22 M
|
$116.51 M
|
$116.13 M
|
$108.54 M
|
$110.23 M
|
$114.12 M
|
| Other Expenses |
$26.21 M
|
$171.64 M
|
$51.29 M
|
$29.71 M
|
$38.46 M
|
$171.18 M
|
$25.41 M
|
$29.59 M
|
$24.98 M
|
$33.92 M
|
| Operating Expenses |
$197.66 M
|
$347.13 M
|
$225.43 M
|
$194.20 M
|
$192.07 M
|
$317.37 M
|
$165.40 M
|
$158.03 M
|
$155.13 M
|
$173.30 M
|
| Cost And Expenses |
$332.45 M
|
$496.35 M
|
$389.93 M
|
$344.69 M
|
$326.29 M
|
$431.26 M
|
$280.03 M
|
$275.83 M
|
$280.96 M
|
$352.87 M
|
| Interest Income |
$978.00 K
|
$1.61 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$11.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$2.70 M
|
$688.00 K
|
$861.00 K
|
$907.00 K
|
$5.10 M
|
$3.06 M
|
$2.84 M
|
$3.40 M
|
| Depreciation & Amortization |
$25.80 M
|
$27.71 M
|
$30.87 M
|
$29.35 M
|
$25.92 M
|
$23.81 M
|
$25.88 M
|
$23.16 M
|
$24.81 M
|
$28.12 M
|
| EBITDA |
$1.74 M |
-$6.13 M |
$12.19 M |
$11.13 M |
-$9.28 M |
-$143.42 M |
$16.28 M |
$8.96 M |
$13.36 M |
$28.25 M |
| EBITDA Ratio |
0.01
|
-0.02
|
0.04
|
0.04
|
-0.03
|
-0.54
|
0.05
|
0.03
|
0.04
|
0.08
|
| Operating Income Ratio |
-0.14
|
-0.63
|
-0.15
|
-0.09
|
-0.12
|
-0.63
|
-0.03
|
-0.04
|
-0.03
|
0
|
| Total Other Income/Expenses Net |
$5.92 M
|
$797.00 K
|
-$3.26 M
|
-$1.48 M
|
-$769.00 K
|
-$1.04 M
|
-$5.31 M
|
-$3.09 M
|
-$3.12 M
|
-$4.27 M
|
| Income Before Tax |
-$34.03 M
|
-$191.64 M
|
-$54.44 M
|
-$29.95 M
|
-$36.05 M
|
-$168.14 M
|
-$14.70 M
|
-$17.26 M
|
-$14.30 M
|
-$3.25 M
|
| Income Before Tax Ratio |
-0.12
|
-0.63
|
-0.16
|
-0.09
|
-0.12
|
-0.64
|
-0.04
|
-0.05
|
-0.04
|
-0.01
|
| Income Tax Expense |
-$39.00 K
|
-$7.29 M
|
-$2.00 M
|
-$3.40 M
|
-$4.50 M
|
-$1.35 M
|
-$3.56 M
|
-$11.04 M
|
-$7.24 M
|
$40.34 M
|
| Net Income |
-$33.99 M
|
-$184.35 M
|
-$52.44 M
|
-$26.55 M
|
-$31.55 M
|
-$166.79 M
|
$61.34 M
|
$16.34 M
|
-$7.05 M
|
-$43.59 M
|
| Net Income Ratio |
-0.12
|
-0.61
|
-0.15
|
-0.08
|
-0.11
|
-0.63
|
0.17
|
0.05
|
-0.02
|
-0.12
|
| EPS |
-0.83 |
-4.59 |
-1.33 |
-0.68 |
-0.82 |
-4.37 |
1.64 |
0.44 |
0.19 |
-1.23 |
| EPS Diluted |
-0.83 |
-4.59 |
-1.33 |
-0.68 |
-0.82 |
-4.37 |
1.64 |
0.44 |
0.19 |
-1.23 |
| Weighted Average Shares Out |
$40.98 M
|
$40.18 M
|
$39.48 M
|
$39.01 M
|
$38.34 M
|
$37.96 M
|
$37.48 M
|
$37.08 M
|
$36.62 M
|
$36.02 M
|
| Weighted Average Shares Out Diluted |
$40.98 M
|
$40.18 M
|
$39.48 M
|
$39.01 M
|
$38.34 M
|
$37.96 M
|
$37.48 M
|
$37.54 M
|
$36.96 M
|
$36.16 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
